Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
SHORT-COURSE RADIOTHERAPY FOR OLDER PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER AND UNFIT FOR CHEMOTHERAPY: THE SOFT STUDYGerardo Rosati, Alfonso De Stefano, Angelo Restivo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant TrialAlberto Sobrero, Sara Lonardi, Gerardo Rosati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trialCarlo Aschele, Luca Cionini, Sara Lonardi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2024
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Phase III ERMES StudyCarmine Pinto, Armando Orlandi, Nicola Normanno, et al.Endoscopy|February 6, 2019
Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) GuidelineCesare Hassan, Piotr Tomasz Wysocki, Lorenzo Fuccio, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real worldValentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.Clinical Colorectal Cancer|July 8, 2020
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER TrialMaria Carmela Piccirillo, Antonio Avallone, Chiara Carlomagno, et al.JAMA Oncology|February 14, 2020
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical TrialFausto Petrelli, Roberto Labianca, Alberto Zaniboni, et al.The Oncologist|January 17, 2020
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup AnalysisGerardo Rosati, Fabio Galli, Maurizio Cantore, et al.Clinical Colorectal Cancer|March 19, 2023
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA TrialDebora Basile, Gerardo Rosati, Francesca Bergamo, et al.Pageof 9